Oncology (ICO-27)

This track focuses on the latest advancements in the discovery and development of novel anticancer agents. Emphasis will be placed on innovative methodologies, including high-throughput screening and drug repurposing strategies.

This session will explore the role of cancer biomarkers in enhancing diagnostic accuracy and prognostic assessments. Discussions will include the identification and validation of biomarkers across various cancer types.

This track will cover recent developments in chemotherapy and radiotherapy techniques aimed at improving treatment efficacy. Topics will include combination therapies and personalized treatment regimens.

This session will examine the epidemiological trends in cancer incidence and the effectiveness of prevention strategies. It will highlight public health initiatives aimed at reducing cancer risk factors.

This track will discuss the integration of complementary therapies in oncology nursing and patient care. The focus will be on evidence-based practices that enhance patient outcomes and quality of life.

This session will address the ethical considerations inherent in oncology research and clinical practice. Topics will include informed consent, patient autonomy, and the implications of emerging technologies.

This track will focus on the translation of laboratory findings into clinical applications in oncology. Emphasis will be placed on collaborative efforts between researchers and clinicians to enhance patient care.

This session will explore the specific challenges faced in the diagnosis and treatment of pediatric cancers. Discussions will include innovative therapies and supportive care strategies tailored for children.

This track will highlight cutting-edge technologies such as nanotechnology and immunotherapy in the field of oncology. The focus will be on how these innovations are shaping the future of cancer treatment.

This session will cover advancements in surgical techniques for cancer treatment and their impact on patient outcomes. Discussions will include minimally invasive approaches and the role of surgery in multimodal treatment plans.

This track will examine the intersection of cancer research, policy, and public health. It will focus on the role of legislation and advocacy in shaping cancer care and prevention strategies.